Design of liposomes as drug delivery system for therapeutic applications
Almutairi M, Batran RA, Ussher JR
Teva, a case involving the cardiovascular drug carvedilol, produced a Federal Circuit ruling in 2021 that found generic manufacturers could face induced infringement liability even under a skinny label if their promotional or marketing activities (including Dear Healthcare Provider letters, press releases, and labeling guidance) communicated an intent to encourage use for the protected indication
This should be of interest to those curious about MDMA, neuropharmacology, the origins of emotional processing in the brain, empathy, PTDS, neuroplasticity, mental health and psychiatry
Folic Acid: Protects the babys neural tube development
Many patients report better outcomes injecting 30 minutes to 1 hour before their largest meal